Granuloma formation around filarial larvae triggered by host responses to an excretory/secretory antigen

Infection and Immunity

Volumn 79, Issue 2, 2011, Pages 838-845

  Dash, Yashodhara ^a   Ramesh, Manish ^a   Kalyanasundaram, Ramaswamy ^b   Munirathinam, Gnanasekar ^b   Shultz, Leonard D ^c   Rajan, T V ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^c JACKSON LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIGEN; BRUGIA MALAYI ABUNDANT LARVAL TRANSCRIPT 2; FILARIA ANTIBODY; FILARIA ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; BACTERIOPHAGE; BRUGIA PAHANGI; CELL ADHESION; CLINICAL ASSESSMENT; CLONING; CONTROLLED STUDY; FILARIASIS; GRANULOMA; HOST RESISTANCE; HYBRIDOMA; IMMUNE ADHERENCE; IMMUNE RESPONSE; IMMUNIZATION; MOUSE; NEMATODE LIFE CYCLE STAGE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, HELMINTH; ANTIGENS, HELMINTH; BRUGIA PAHANGI; EPITOPES; FILARIASIS; GRANULOMA; HYBRIDOMAS; IMMUNOGLOBULIN M; INTEGUMENTARY SYSTEM; LARVA; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; RECOMBINANT PROTEINS; SPECIFIC PATHOGEN-FREE ORGANISMS; VACCINES;

EID: 79251491998     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00128-10     Document Type: Article

References (18)

1. Anand, S. B., et al. 2008. Comparison of immunogenicity, protective efficacy of single and cocktail DNA vaccine of Brugia malayi abundant larval transcript (ALT-2) and thioredoxin peroxidase (TPX) in mice. Acta Trop. 107: 106-112.
2. Boes, M. 2000. Role of natural and immune IgM antibodies in immune responses. Mol. Immunol. 37:1141-1149.
3. Boes, M., et al. 1998. Enhanced B-1 cell development, but impaired IgG antibody responses in mice deficient in secreted IgM. J. Immunol. 160:4776-4787.
4. Gnanasekar, M., et al. 2004. Novel phage display-based subtractive screening to identify vaccine candidates of Brugia malayi. Infect. Immun. 72:4707-4715.
5. Gomez-Escobar, N., et al. 2002. Abundant larval transcript-1 and -2 genes from Brugia malayi: diversity of genomic environments but conservation of 5′ promoter sequences functional in Caenorhabditis elegans. Mol. Biochem. Parasitol. 125:59-71.
6. Gregory, W. F., A. K. Atmadja, J. E. Allen, and R. M. Maizels. 2000. The abundant larval transcript-1 and -2 genes of Brugia malayi encode stage-specific candidate vaccine antigens for filariasis. Infect. Immun. 68:4174-4179.
7. Herion, P., C. Glineur, J. D. Franssen, J. Urbain, and A. Bollen. 1981. Monoclonal antibodies against urokinase. Biosci. Rep. 1:885-892.
8. Nelson, F. K., D. L. Greiner, L. D. Shultz, and T. V. Rajan. 1991. The immunodeficient scid mouse as a model for human lymphatic filariasis. J. Exp. Med. 173:659-663.
9. Paciorkowski, N., P. Porte, L. D. Shultz, and T. V. Rajan. 2000. B1 B lymphocytes play a critical role in host protection against lymphatic filarial parasites. J. Exp. Med. 191:731-736.
10. Rajan, B., T. Ramalingam, and T. V. Rajan. 2005. Critical role for IgM in host protection in experimental filarial infection. J. Immunol. 175:1827-1833.
11. Rajan, T. V., et al. 2002. Brugian infections in the peritoneal cavities of laboratory mice: kinetics of infection and cellular responses. Exp. Parasitol. 100:235-247.
12. Rajan, T. V., N. Paciorkowski, I. Kalajzic, and C. McGuiness. 2003. Ascorbic acid is a requirement for the morphogenesis of the human filarial parasite Brugia malayi. J. Parasitol. 89:868-870.
13. Ramachandran, S., et al. 2004. The larval specific lymphatic filarial ALT-2: induction of protection using protein or DNA vaccination. Microbiol. Immunol. 48:945-955.
14. Ramesh, M., C. McGuiness, and T. V. Rajan. 2005. The L3 to L4 molt of Brugia malayi: real time visualization by video microscopy. J. Parasitol. 91:1028-1033.
15. Spencer, L., L. Shultz, and T. V. Rajan. 2003. T cells are required for host protection against Brugia malayi but need not produce or respond to interleukin-4. Infect. Immun. 71:3097-3106.
16. Thirugnanam, S., et al. 2007. Brugia malayi: comparison of protective immune responses induced by Bmalt-2 DNA, recombinant BmALT-2 protein and prime-boost vaccine regimens in a jird model. Exp. Parasitol. 116:483-491.
17. Vanam, U., et al. 2009. Evaluation of immunoprophylactic efficacy of Brugia malayi transglutaminase (BmTGA) in single and multiple antigen vaccination with BmALT-2 and BmTPX for human lymphatic filariasis. Am. J. Trop. Med. Hyg. 80:319-324.
18. Yates, J. A., K. A. Schmitz, F. K. Nelson, and T. V. Rajan. 1994. Infectivity and normal development of third stage Brugia malayi maintained in vitro. J. Parasitol. 80:891-894.